What are some of the department’s most satisfying successes of the past year and why? Only a small handful of securities cases (out of the thousands filed in the past 30 years) have gone all the way to a trial verdict, and Latham is one of the few major law firms to have taken not just one, but several of these cases through trial. Latham recently secured a jury trial win for Puma Biotechnology in the first federal securities class action to reach a verdict in nearly 10 years. In the same period, a Latham team represented UBS Securities before the New York Supreme Court in a high-profile lawsuit against Highland Capital.

Clients consistently turn to Latham to try their bet-the-company cases, but it is extremely rare to have one trial in this space in a single calendar year, let alone two. And Latham is gearing up for a third trial this December, on behalf of Walworth, the investment vehicle for the Ryan family, which is seeking hundreds of millions for alleged fraud in connection with the buyback of shares by Mu Sigma.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]